Sign in if you already have an account.
  
donate.gif

Thank You
Thanks to Participants, Supporters, Sponsors, and Volunteers
(and Mother Nature)

2013 Komen CNY Race for the Cure
was a great success

Keep up the momentum!
Donations will be accepted through July 14
If you don't ask, they can't say "Yes!"

Qualify for great rewards
Click here for more info

Affiliate News

Angelina Jolie decides to undergo double mastectomy to reduce her chances of developing breast cancer
In her own words, Jolie says, "the truth is I carry a “faulty” gene, BRCA1, which sharply increases my risk of developing breast cancer and ovarian cancer. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. Read her article and learn about heredity and breast cancer..
More

Summer Skin Care and Breast Cancer
Treatments for breast cancer also can affect skin at times, leaving it dry or flaky and more sensitive to exposure to sun, wind, and other elements..
More

National Women's Health Week - May 12 - May 18
Take care of yourself this week - participate in the CNY Race for the Cure on May 18 - it's empowering..
More

more
Affiliate Monthly
Race Results Now Available

Race Results are viewable online.

Click here to go to Race results
Race 2013 Photographs

The photographers caught the spirit of the Race. Be sure to check out the photos and find yourself and friends making the Race a successful and meaningful day.

Click here to view and purchase photos
Spring 2013 Pink in Print Newsletter

Learn about the most up-to-date breast cancer news and what is happening in Central New York

Download the Komen CNY Newsletter
more
National Spotlight

Is ductal carcinoma in situ (DCIS) breast cancer?
Ductal carcinoma in situ (DCIS) is breast cancer, but it is non-invasive. About 55,000 new cases of DCIS are expected to be diagnosed among women in the U.S. in 2013. Learn more now.

Life after breast cancer booklet

How Komen's research investment has changed the breast cancer landscape
As we've come to understand more about the biology of breast cancer, Komen's research agenda has changed tremendously over the past 10-15 years. Read more about Komen's research investment.

Researchers conducting clinical trials
more